Mebeverine Hydrochloride BP 135 mg Tablet.
Meverine is indicated for the symptomatic treatment of irritable bowel syndromme and other conditions usually included in this grouping such as: chronic irritable colon, spastic constipation, mucous colitis, spastic colitis. Meverine is also effective in colicky abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence. For the symptomatic treatment of gastrointestinal spasm secondary to organic diseases. Meverine-SR : Mebeverine Hydrochloride is indicated: For the symptomatic treatment of irritable bowel syndrome (IBS), other conditions include: Chronic irritable colon, Spastic constipation, Mucous Colitis, Colicky abdominal pain, Persistent non-specific diarrhoea.
Mebeverine Hydrochloride BP 135 mg Tablet.
Meverine is indicated for the symptomatic treatment of irritable bowel syndromme and other conditions usually included in this grouping such as: chronic irritable colon, spastic constipation, mucous colitis, spastic colitis. Meverine is also effective in colicky abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence. For the symptomatic treatment of gastrointestinal spasm secondary to organic diseases. Meverine-SR : Mebeverine Hydrochloride is indicated: For the symptomatic treatment of irritable bowel syndrome (IBS), other conditions include: Chronic irritable colon, Spastic constipation, Mucous Colitis, Colicky abdominal pain, Persistent non-specific diarrhoea.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.